Blair Keagy, MD, CEO, is pleased to announce the launch of MPAnalytics, Inc. - a medical consultant group dedicated to helping businesses evaluate the commercial potential of new medical products and technologies.
CHAPEL HILL, N.C. (Business Wire EON) November 17, 2008 -- MPAnalytics provides market analysis and recommendations for new medical devices and technology based on five key parameters: scientific merit, reimbursement potential, competition and clinical potential, practical market potential and clinical trial analysis. The founders of MPAnalytics have extensive clinical experience as well as knowledge of clinical trial design, reimbursement issues and practical markets for new medical devices and technologies.
"I credit my colleagues at the UNC School of Medicine and the Kenan-Flaghler Launching the Venture Program with helping to get this business off the ground," states Dr. Keagy. "Now, we have clients enthusiastically soliciting our help in assessing the business potential of their new medical devices or ideas before investing significant monies in development or clinical trial."
clinical trial, clinical trial specialist, consultant, medical, market analysis, medical advisory board, medical consultant, medical device consultant, medical device consultants, medical device quality consultants, medical devices consultant, mpanalytics, new medical devices
Read the full story at http://www.prweb.com/releases/medical_consultant/blair_keagy/prweb1627584.htm
Copyright©2008 Vocus, Inc.
All rights reserved